Biopharmaceutical 3PL Market Size, Share, Trends, Growth 2032

Biopharmaceutical 3PL Market

Biopharmaceutical 3PL Market By Supply Chain (Cold Chain and Non-Cold Chain), By Service Type (Transportation, Warehousing, and Storage), and By Region - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024 - 2032

Category: Pharmaceutical Report Format : PDF Pages: 150 Report Code: ZMR-6403 Published Date: Nov-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 118.35 Billion USD 195.78 Billion 5.2% 2023

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Biopharmaceutical 3PL Market, 2016–2026 (USD Billion)
    • 2.2. Biopharmaceutical 3PL Market: Snapshot
  • Chapter 3. Global Biopharmaceutical 3PL Market– Industry Analysis
    • 3.1. Biopharmaceutical 3PL Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Escalating preference for outsourcing logistics and huge focus of giant pharma firms on expanding their distribution networks with huge product sales will steer biopharmaceutical 3PL market size over 2020-2026.
      • 3.2.2. Surge in new biosimilar launches will embellish market trends. Moreover, advent of spectrum of biosimilars, generic medicines, and biulogics will favorably leverage biopharmaceutical 3PL industry growth in the upcoming years.
    • 3.3. Porter’s Five Forces Analysis
    • 3.4. Market Attractiveness Analysis
      • 3.4.1. Market attractiveness analysis By Service Type
      • 3.4.2. Market attractiveness analysis By Supply Chain
  • Chapter 4. Global Biopharmaceutical 3PL Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Biopharmaceutical 3PL Market: company market share, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Service launches
      • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Biopharmaceutical 3PL Market– Service Type Analysis
    • 5.1. Global Biopharmaceutical 3PL Market overview: By Service Type
      • 5.1.1. Global Biopharmaceutical 3PL Market share, By Service Type , 2019 and 2026
    • 5.2. Warehousing
      • 5.2.1. Global Biopharmaceutical 3PL Market By Warehousing, 2016–2026 (USD Billion)
    • 5.3. Transportation
      • 5.3.1. Global Biopharmaceutical 3PL Market By Transportation, 2016–2026 (USD Billion)
    • 5.4. Storage
      • 5.4.1. Global Biopharmaceutical 3PL Market By Storage, 2016–2026 (USD Billion)
  • Chapter 6. Global Biopharmaceutical 3PL Market– Supply Chain Analysis
    • 6.1. Global Biopharmaceutical 3PL Market overview: By Supply Chain
      • 6.1.1. Global Biopharmaceutical 3PL Market share, By Supply Chain, 2019 and 2026
    • 6.2. Culd Chain
      • 6.2.1. Global Biopharmaceutical 3PL Market By Culd Chain , 2016–2026 (USD Billion)
    • 6.3. Non-Culd Chain
      • 6.3.1. Global Biopharmaceutical 3PL Market By Non-Culd Chain, 2016–2026 (USD Billion)
  • Chapter 7. Company Profiles
    • 7.1. FedEx
      • 7.1.1. Overview
      • 7.1.2. Financials
      • 7.1.3. Service Portfolio
      • 7.1.4. Business Strategy
      • 7.1.5. Recent Developments
    • 7.2. DB Schenker
      • 7.2.1. Overview
      • 7.2.2. Financials
      • 7.2.3. Service Portfolio
      • 7.2.4. Business Strategy
      • 7.2.5. Recent Developments
    • 7.3. SF Express
      • 7.3.1. Overview
      • 7.3.2. Financials
      • 7.3.3. Service Portfolio
      • 7.3.4. Business Strategy
      • 7.3.5. Recent Developments
    • 7.4. DHL International GmbH
      • 7.4.1. Overview
      • 7.4.2. Financials
      • 7.4.3. Service Portfolio
      • 7.4.4. Business Strategy
      • 7.4.5. Recent Developments
    • 7.5. United Parcel Service of America, Inc.
      • 7.5.1. Overview
      • 7.5.2. Financials
      • 7.5.3. Service Portfolio
      • 7.5.4. Business Strategy
      • 7.5.5. Recent Development
    • 7.6. Kerry Logistics Network Limited
      • 7.6.1. Overview
      • 7.6.2. Financials
      • 7.6.3. Service Portfolio
      • 7.6.4. Business Strategy
      • 7.6.5. Recent Development
    • 7.7. AmerisourceBergen Corporation
      • 7.7.1. Overview
      • 7.7.2. Financials
      • 7.7.3. Service Portfolio
      • 7.7.4. Business Strategy
      • 7.7.5. Recent Development
    • 7.8. KUEHNE + NAGEL.
      • 7.8.1. Overview
      • 7.8.2. Financials
      • 7.8.3. Service Portfolio
      • 7.8.4. Business Strategy
      • 7.8.5. Recent Development

Table Of Figures

List of Figures

1. Market research process
2. Market research methodology
3. Global Biopharmaceutical  3PL Market, 2016–2026 (USD Billion)
4. Porter’s Five Forces Analysis
5. Global Biopharmaceutical  3PL Market attractiveness, By Service Type
6. Global Biopharmaceutical  3PL Market attractiveness, By Supply Chain
7. Global Biopharmaceutical  3PL Market Share by Service Type ,2019 and 2026 (USD Billion)
8. Global Biopharmaceutical  3PL Market by Warehousing, 2016–2026 (USD Billion)
9. Global Biopharmaceutical  3PL Market by Transportation, 2016–2026 (USD Billion)
10. Global Biopharmaceutical  3PL Market by Storage,2016–2026 (USD Billion)
11. Global Biopharmaceutical  3PL Market Share by Supply Chain ,2019 and 2026 (USD Billion)
12. Global Biopharmaceutical  3PL Market by Cold Chain  , and,2016–2026 (USD Billion)
13. Global Biopharmaceutical  3PL Market by Non-Cold Chain,2016–2026 (USD Billion)
14. Global Biopharmaceutical  3PL Market share, by Region, 2019 and 2026
15. North America Biopharmaceutical  3PL Market, 2016–2026 (USD Billion)
16. Europe Biopharmaceutical  3PL Market, 2016–2026 (USD Billion)
17. Asia Pacific Biopharmaceutical  3PL Market, 2016–2026 (USD Billion)
18. Latin America Biopharmaceutical  3PL Market, 2016–2026 (USD Billion)
19. The Middle East and Africa Biopharmaceutical  3PL Market, 2016–2026 (USD Billion)


Table Of Tables

List of Tables

1. Global Biopharmaceutical  3PL Market: snapshot
2. Drivers of the Biopharmaceutical  3PL Market: impact analysis
3. North America Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
4. North America Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
5. The U.S. Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
6. The U.S. Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
7. Rest of North America Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
8.  Rest of North America Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
9.  Europe Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
10. Europe Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
11. UK Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
12. UK Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
13. France Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
14. France Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
15. Germany Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
16. Germany Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
17. Rest of Europe Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
18. Rest of Europe Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
19. Asia Pacific Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
20. Asia Pacific Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
21. China Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
22. China Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
23. Japan  Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
24. Japan Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
25. India Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
26. India Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
27. Rest of Asia Pacific Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
28. Rest of Asia Pacific Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
29. Latin America Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
30. Latin America Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
31. Brazil Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
32. Brazil Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
33. Rest of Latin America Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
34. Rest of Latin America Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
35. The Middle East and Africa Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
36. The Middle East and Africa Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
37. Saudi Arabia Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
38. Saudi Arabia Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
39. South Africa Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
40. South Africa Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
41. Rest of the Middle East & Africa Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
42. Rest of the Middle East & Africa Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)


  


 
 

Methodology

FrequentlyAsked Questions

Biopharmaceutical 3PL provides logistics for biotech products. It manages storage, transport, and compliance

The global Biopharmaceutical 3PL market is expected to be driven by the outsourcing trends and need for temperature-controlled logistics. Growth in biologics and vaccines supports market expansion.

According to study, the global Biopharmaceutical 3PL market size was worth around USD 118.35 Billion in 2023 and is predicted to grow to around USD 195.78 Billion By 2032.

The global Biopharmaceutical 3PL market is expected to grow at a Compound Annual Growth Rate (CAGR) of around CAGR 5.2% during the forecast period from 2024-2032.

The global Biopharmaceutical 3PL industry is projected to be challenged by Challenges include cold-chain complexity, regulatory compliance, and high operational costs.

The Opportunities include biologics growth, outsourcing trends, global clinical trials, and specialized pharma logistics will offer significant growth opportunities in the Biopharmaceutical 3PL market.

Cold-chain and specialty logistics expansion; digital track-and-trace; compliance-driven outsourcing growth are the emerging trends and innovations impacting the Biopharmaceutical 3PL market.

The global Biopharmaceutical 3PL market is expected to be led by North America during the forecast period.

Some of the prominent players operating in the global Biopharmaceutical 3PL market are; FedEx, DB Schenker, SF Express, DHL International GmbH, United Parcel Service of America, Inc., Kerry Logistics Network Limited, AmerisourceBergen Corporation, and KUEHNE + NAGEL. and others.

The report explores crucial aspects of the Biopharmaceutical 3PL market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.

  • zion payment modes

List of Contents

What is the Market Size?OverviewGrowth DynamicsReport ScopeMarket:Regional LandscapeMarket:Competitive LandscapeThe global Market is segmented as follows:

HappyClients